Compound Evidence File
#EC-2026-0644
EPO
Filed under Peptides. The bureau holds 208 laboratory returns for this compound from 99 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
99 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 5 Apr 2026 | 15 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 4 Dec 2025 | 18 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Dec 2025 | 21 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 10.0 | 10.0 | 16 Feb 2026 | 9 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 10.0 | 10.0 | 9 Apr 2026 | 23 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 10.0 | 10.0 | 25 Jan 2026 | 21 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Jul 2026 | 15 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 10.0 | 10.0 | 9 May 2026 | 26 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 10.0 | 10.0 | 21 Jan 2026 | 20 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 11 Feb 2026 | 11 Jun 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 10.0 | 10.0 | 10.0 | 8 Jul 2025 | 8 Jul 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jun 2025 | 3 Jun 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Jan 2026 | 22 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 2 Jan 2026 | 8 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 25 Apr 2026 | 7 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 17 Dec 2025 | 2 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 19 Nov 2025 | 3 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 24 Apr 2026 | 2 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 9.9 | 18 Apr 2026 | 7 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 9.9 | 3 Jul 2026 | 18 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 21 Jan 2026 | 6 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 12 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 7 May 2026 | 23 Jun 2026 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 9.9 | 9.9 | 9.9 | 3 Jun 2025 | 3 Jun 2025 |
| Peptide PartnersCASE #VI-2026-0295 | X | 5 | 9.2 | 7.7 | 10.0 | 25 Apr 2025 | 20 May 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 9.2 | 9.2 | 9.2 | 20 Jun 2025 | 20 Jun 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.8 | 7.1 | 9.9 | 24 May 2026 | 24 May 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 8.8 | 8.8 | 8.8 | 6 May 2025 | 6 May 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.6 | 7.0 | 9.6 | 24 May 2026 | 24 May 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 8.6 | 8.6 | 8.6 | 16 Mar 2025 | 16 Mar 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.4 | 6.9 | 9.8 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.4 | 6.8 | 9.9 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.4 | 7.7 | 9.2 | 24 May 2026 | 24 May 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 8.3 | 8.3 | 8.3 | 25 Apr 2025 | 25 Apr 2025 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 8.2 | 8.2 | 8.2 | 6 May 2025 | 6 May 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 8.2 | 8.2 | 8.2 | 20 Jun 2025 | 20 Jun 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 8.2 | 8.2 | 8.2 | 9 Jun 2025 | 9 Jun 2025 |
| LSPLCASE #VI-2026-0523 | X | 3 | 8.1 | 6.7 | 9.4 | 24 Apr 2025 | 24 May 2026 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 8.1 | 8.1 | 8.1 | 13 Feb 2025 | 13 Feb 2025 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 8.0 | 8.0 | 8.0 | 13 Jun 2025 | 13 Jun 2025 |
| CellupepCASE #VI-2026-0888 | X | 1 | 8.0 | 8.0 | 8.0 | 9 Jun 2025 | 9 Jun 2025 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 | 11 Jun 2025 |
| HealthTide BiotechCASE #VI-2026-0955 | X | 1 | 7.8 | 7.8 | 7.8 | 14 Jan 2025 | 14 Jan 2025 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 | 8 Jul 2025 |
| Mai PeptideCASE #VI-2026-0769 | X | 3 | 7.6 | 5.9 | 8.6 | 3 Jul 2025 | 19 Jan 2026 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 2 | 7.6 | 7.1 | 8.2 | 20 Jun 2025 | 21 May 2026 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 7.6 | 7.6 | 7.6 | 21 May 2025 | 21 May 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 1 | 7.5 | 7.5 | 7.5 | 11 Jun 2025 | 11 Jun 2025 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 7.5 | 7.5 | 7.5 | 6 May 2025 | 6 May 2025 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 7.3 | 7.3 | 7.3 | 11 Jun 2025 | 11 Jun 2025 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 4 | 7.2 | 5.8 | 8.1 | 6 May 2025 | 23 May 2026 |
| Pure RawzCASE #VI-2026-0767 | X | 2 | 7.2 | 7.0 | 7.4 | 16 Mar 2025 | 19 Jan 2026 |
| Platinum CryoCASE #VI-2026-0406 | X | 2 | 7.2 | 6.0 | 8.3 | 14 Jan 2025 | 21 May 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.2 | 7.2 | 7.2 | 16 Mar 2025 | 16 Mar 2025 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 | 25 Apr 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 | 13 Feb 2025 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 1 | 7.0 | 7.0 | 7.0 | 13 Feb 2025 | 13 Feb 2025 |
| Verified PeptidesCASE #VI-2026-0407 | X | 2 | 6.9 | 6.2 | 7.6 | 16 Mar 2025 | 21 May 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 6.9 | 6.9 | 6.9 | 13 Jun 2025 | 13 Jun 2025 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 6.9 | 6.9 | 6.9 | 9 Jun 2025 | 9 Jun 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 6.8 | 6.8 | 6.8 | 14 Jan 2025 | 14 Jan 2025 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 6.4 | 6.4 | 6.4 | 27 Feb 2025 | 27 Feb 2025 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 6.4 | 6.4 | 6.4 | 3 Jun 2025 | 3 Jun 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 3 | 6.3 | 3.6 | 8.9 | 28 Mar 2025 | 20 May 2026 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 6.3 | 6.3 | 6.3 | 24 Apr 2025 | 24 Apr 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 6.3 | 6.3 | 6.3 | 3 Jul 2025 | 3 Jul 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 6.3 | 6.3 | 6.3 | 13 Jun 2025 | 13 Jun 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 | 28 Mar 2025 |
| UtherCASE #VI-2026-0902 | X | 2 | 6.2 | 5.9 | 6.4 | 7 May 2025 | 20 May 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 6.2 | 6.2 | 6.2 | 21 May 2025 | 21 May 2025 |
| Peptide SciencesCASE #VI-2026-0867 | X | 3 | 6.1 | 4.6 | 7.4 | 6 May 2025 | 19 Jan 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 1 | 6.1 | 6.1 | 6.1 | 3 Jul 2025 | 3 Jul 2025 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 4 | 6.0 | 4.9 | 6.8 | 9 Jun 2025 | 21 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 6.0 | 5.2 | 6.7 | 13 Jun 2025 | 24 May 2026 |
| Amino AmigosCASE #VI-2026-0061 | X | 1 | 6.0 | 6.0 | 6.0 | 14 Jan 2025 | 14 Jan 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 5.7 | 5.7 | 5.7 | 25 Apr 2025 | 25 Apr 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 4 | 5.5 | 3.3 | 6.8 | 9 Jun 2025 | 24 May 2026 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 1 | 5.3 | 5.3 | 5.3 | 14 Jan 2025 | 14 Jan 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 4 | 5.2 | 3.3 | 7.3 | 3 Jul 2025 | 17 May 2026 |
| Elite Research USACASE #VI-2026-0267 | X | 2 | 5.2 | 3.1 | 7.3 | 13 Feb 2025 | 23 May 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 5.2 | 5.2 | 5.2 | 13 Feb 2025 | 13 Feb 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 4.8 | 4.8 | 4.8 | 21 May 2025 | 21 May 2025 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 4.7 | 4.7 | 4.7 | 16 Mar 2025 | 16 Mar 2025 |
| TydesCASE #VI-2026-0493 | X | 2 | 4.5 | 3.3 | 5.8 | 21 May 2025 | 26 Jan 2026 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 1 | 4.1 | 4.1 | 4.1 | 13 Feb 2025 | 13 Feb 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 3.7 | 3.7 | 3.7 | 7 May 2025 | 7 May 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 3.7 | 3.7 | 3.7 | 7 May 2025 | 7 May 2025 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 3.3 | 3.3 | 3.3 | 27 Feb 2025 | 27 Feb 2025 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 3.3 | 3.3 | 3.3 | 2 Jul 2025 | 2 Jul 2025 |
| Zztai PeptideCASE #VI-2026-0192 | X | 1 | 3.2 | 3.2 | 3.2 | 9 Jun 2025 | 9 Jun 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 1.7 | 1.7 | 1.7 | 16 Mar 2025 | 16 Mar 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 1.6 | 1.6 | 1.6 | 2 Jul 2025 | 2 Jul 2025 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 0.5 | 0.5 | 0.5 | 28 Mar 2025 | 28 Mar 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.0 | 0.0 | 0.0 | 16 Mar 2025 | 16 Mar 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 0.0 | 0.0 | 0.0 | 20 Jun 2025 | 20 Jun 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Feb 2025 | 13 Feb 2025 |
Open any subject to view the batch-level evidence for EPO alone.